-
May 29, 2026 iProgen Out-Licenses AntibodyInternalization Technologies to AOCeraTherapeutics for Antibody Oligo ConjugateApplication.May 29, 2026iProgen Biotech out-licensed its Antibody Internalization Technologies to AOCeraTherapeutics Inc. (www.AOCera.com), headquartered in San Diego, USA....
-
June 25, 2025 iProgen and UBC Out-License NovelDegrader Antibody ConjugateTechnology to 3C Therapeutics Inc.iProgen Biotech and the University of British Columbia (UBC) have jointly out-licensed their novel modular Degrader Antibody Conjugate...
-
September 3, 2024 iProgen has out-licensed its protein internalization technology to Lucy Biotech Ltd. for the delivery of Anti-Freeze ProteinsiProgen Biotech out-licensed its intracellular protein delivery technology for enhanced delivery of antifreeze proteins to Lucy Biotech Ltd.,...
